Total Payments
$53,327
2024 Payments
$5,635
Companies
35
Transactions
173
Medicare Patients
1,431
Medicare Billing
$407,675
Payment Breakdown by Category
Other$37,674 (70.6%)
Travel$5,912 (11.1%)
Consulting$5,303 (9.9%)
Food & Beverage$4,395 (8.2%)
Education$43.18 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $25,944 | 23 | 48.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,730 | 15 | 22.0% |
| Travel and Lodging | $5,912 | 8 | 11.1% |
| Consulting Fee | $5,303 | 9 | 9.9% |
| Food and Beverage | $4,395 | 116 | 8.2% |
| Education | $43.18 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Karyopharm Therapeutics Inc. | $32,216 | 55 | $0 (2024) |
| Janssen Biotech, Inc. | $17,992 | 32 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $936.53 | 7 | $0 (2024) |
| PFIZER INC. | $398.21 | 13 | $0 (2024) |
| Incyte Corporation | $298.96 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $189.48 | 13 | $0 (2024) |
| Seagen Inc. | $154.13 | 5 | $0 (2022) |
| ABBVIE INC. | $130.76 | 6 | $0 (2024) |
| Novocure Inc. | $124.92 | 1 | $0 (2021) |
| BeiGene USA, Inc. | $124.89 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,635 | 58 | Karyopharm Therapeutics Inc. ($2,853) |
| 2023 | $20,821 | 48 | Janssen Biotech, Inc. ($12,810) |
| 2022 | $14,776 | 45 | Karyopharm Therapeutics Inc. ($10,657) |
| 2021 | $12,094 | 22 | Karyopharm Therapeutics Inc. ($11,344) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | PFIZER INC. | ELREXFIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $180.00 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $12.65 | General |
| Category: Hematology/Oncology | ||||||
| 11/22/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $51.20 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Honoraria | Cash or cash equivalent | $1,250.00 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $69.49 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $24.29 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/10/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: CELLT | ||||||
| 10/03/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: BioOncology | ||||||
| 09/25/2024 | Amneal Pharmaceuticals LLC | AVASTIN (Drug), NEULASTA, NEUPOGEN | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 17 | 17 | $340.00 | $129.37 |
| 2022 | 16 | 461 | 3,540 | $327,131 | $122,168 |
| 2021 | 18 | 804 | 8,208 | $738,036 | $281,303 |
| 2020 | 8 | 149 | 180 | $19,325 | $4,075 |
Total Patients
1,431
Total Services
11,945
Medicare Billing
$407,675
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 17 | 17 | $340.00 | $129.37 | 38.1% |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2022 | 14 | 2,880 | $267,840 | $104,330 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 89 | $22,900 | $5,807 | 25.4% |
| M0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise | Office | 2022 | 15 | 30 | $3,300 | $3,065 | 92.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 20 | $6,725 | $2,101 | 31.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 14 | 17 | $5,100 | $1,444 | 28.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 19 | 27 | $4,725 | $1,281 | 27.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 17 | 20 | $3,000 | $845.47 | 28.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 93 | 104 | $2,080 | $802.80 | 38.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 68 | 76 | $3,040 | $798.36 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $2,675 | $603.28 | 22.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 16 | 34 | $1,870 | $340.27 | 18.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 26 | 36 | $2,160 | $309.52 | 14.3% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 32 | 36 | $900.00 | $216.72 | 24.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2022 | 12 | 15 | $660.00 | $201.26 | 30.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 130 | $130.00 | $11.56 | 8.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2022 | 11 | 13 | $26.00 | $11.40 | 43.8% |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2021 | 11 | 4,860 | $451,980 | $173,484 | 38.4% |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2021 | 12 | 1,830 | $135,420 | $61,116 | 45.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 282 | $70,500 | $22,550 | 32.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 75 | $23,500 | $8,190 | 34.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 29 | 51 | $15,300 | $4,474 | 29.2% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 25 | 62 | $10,750 | $3,151 | 29.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 119 | 207 | $8,280 | $2,186 | 26.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 147 | 253 | $5,060 | $1,966 | 38.9% |
About Kari Cunningham, APRN
Kari Cunningham, APRN is a Nurse Practitioner healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1750534657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kari Cunningham, APRN has received a total of $53,327 in payments from pharmaceutical and medical device companies, with $5,635 received in 2024. These payments were reported across 173 transactions from 35 companies. The most common payment nature is "Honoraria" ($25,944).
As a Medicare-enrolled provider, Cunningham has provided services to 1,431 Medicare beneficiaries, totaling 11,945 services with total Medicare billing of $407,675. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Omaha, NE
- Active Since 10/23/2008
- Last Updated 11/14/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1750534657
Products in Payments
- XPOVIO (Drug) $32,216
- DARZALEX (Biological) $15,955
- TECVAYLI (Biological) $2,148
- MONJUVI (Drug) $263.34
- ELREXFIO (Drug) $210.37
- IMBRUVICA (Drug) $198.15
- TUKYSA (Drug) $129.00
- Optune (Device) $124.92
- BRUKINSA (Drug) $124.89
- Epkinly (Drug) $111.03
- CARVYKTI (Drug) $97.81
- Enhertu (Drug) $95.61
- TALVEY (Biological) $90.00
- LIBTAYO (Biological) $82.06
- SARCLISA (Biological) $64.18
- IBRANCE (Drug) $57.51
- ERLEADA (Drug) $57.45
- VENCLEXTA (Drug) $54.91
- clonoSEQ (Device) $51.20
- EPKINLY (Drug) $44.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Omaha
Ms. Kristen Hammes, Aprn, APRN
Nurse Practitioner — Payments: $816,075
Nurse Practitioner $816,075
Laura Donovan, Aprn, APRN
Nurse Practitioner — Payments: $40,286
Nurse Practitioner $40,286
Kathleen Healey, Aprn, APRN
Nurse Practitioner — Payments: $35,367
Nurse Practitioner $35,367
Ms. Katie Ruch, Aprn, APRN
Nurse Practitioner — Payments: $25,880
Nurse Practitioner $25,880
Leslie Dvorak, Aprn, APRN
Nurse Practitioner — Payments: $25,732
Nurse Practitioner $25,732
Cara Schiessler, Aprn, APRN
Nurse Practitioner — Payments: $13,375
Nurse Practitioner $13,375